Biotech

All Articles

Ultragenyx modifies gene treatment dosing to dial up efficacy

.A minority of people taking Ultragenyx Drug's Wilson disease genetics therapy UX701 have actually g...

Biopharma cutback fee stabilizes in Q3: Tough Biotech evaluation

.As summer warm looks to cool down winds, really hopes that this year will deliver widespread field ...

J &amp J drops period 2 dengue candidate in latest shift coming from vaccines

.Johnson &amp Johnson's deprioritization of its transmittable ailment pipeline has actually professe...

Relay sheds 10% of team after earlier unemployments in July

.Accuracy medicine biotech Relay Therapeutics is actually losing approximately 10% of its own staff ...

Pentixapharm ratings $22M IPO to loan radiopharma trials

.Pentixapharm has produced almost 20 million euros ($ 22 thousand) coming from an IPO, with the Germ...

Lundbeck taps Charles River for AI-enabled neuro medicine invention

.Lundbeck has tapped Charles River Laboratories' artificial intelligence capacities to aid the disco...

Big pharma, biotech 'will not always be symbiotic' in artificial intelligence: S&ampP

.Major Pharma is committing highly in artificial intelligence to lower progression timetables as wel...

I &amp I biotech Triveni raises $115M for preclinical antitoxins

.Triveni Bio has actually trapped $115 thousand in series B funds to progress preclinical antibody s...

IGM turns from cancer to autoimmune, agitating C-suite

.IGM Biosciences ended in 2015 giving up staff as well as streamlining its cancer pipeline. Currentl...

Shattuck centers CD47 program over weak efficacy records, lays off 40% of staff and also sheds Ono deal

.Shattuck Labs has actually knocked one more nail into the coffin of CD47. After seeing a "moderate"...